Dosage ; Adult: 500mg- 1g OD or BD.
Gout 750mg initially then 250mg TID.
Musculoskeletal disorders: 250mg TID or QID PRN
(max 1250mg daily after the first day).
Children 5-16 years: 10mg/kg body weight in two divided doses
| Brand Name | Manufacturer Name | Distributor | Drug Strength | Packaging | Formulation | Formulation Strength | Price |
|---|---|---|---|---|---|---|---|
| Naprosyn | Roche | Roche Products | 500mg | 100 | Tablet | per tablet | KES 5,724 |
| Naproxen more info | |
|---|---|
| Mode Of Action | Selective inhibitor of activated factor X that blocks both thrombin and thrombus formation |
| Drug Indication | Mild to moderate pain, antipyretic, fibrositis, osteoarthritis, rheumatic spondylitis, ankylosing spondylitis. |
| Precautions | Asthma, bronchospasm, elderly, bleeding disorders, impaired renal/hepatic disorders, concomitant anticoagulant therapy, cirrhosis, peptic ulceration, cardiovascular disturbances. |
| Contra-Indications | Peptic ulcers, hypersensitivity to naproxen or cross sensitivity with other NSAIDs. |
| Side Effects | Bronchospasm, GI disturbances, CNS effects, visual changes, blood dyscrasia, hypersensitivity reactions, renal impairment and cystitis. |
| Dosage | Adult: 500mg- 1g OD or BD. Gout 750mg initially then 250mg TID. Musculoskeletal disorders: 250mg TID or QID PRN (max 1250mg daily after the first day). Children 5-16 years: 10mg/kg body weight in two divided doses |
| Pregnancy Category | Category C |
| Pregnancy Category Description | Drugs which, owing to their pharmacological effects, or may be suspected of causing detrimental effects on human foetus or neonates without causing malfunctions. These effects may be reversible |
| Drug Category | DRUGS ACTING ON CNS |
| Drug Sub-Category | Analgesics, Antipyretics & NSAIDS |